Decreased iNOS synthesis mediates dexamethasone-induced protection of neurons from inflammatory injury in vitro

European Journal of Neuroscience

Volumn 18, Issue 9, 2003, Pages 2527-2537

  Golde, Sabine ^a,b   Coles, Alasdair ^c   Lindquist, Jonathan A ^a   Compston, Alastair ^b,c  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Dexamethasone; Microglia; Multiple sclerosis; Nitric oxide; Rat

Indexed keywords

DEXAMETHASONE; GAMMA INTERFERON; MIFEPRISTONE; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; ENZYME SYNTHESIS; IMMUNOCYTOCHEMISTRY; MICROGLIA; NEUROGENIC INFLAMMATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STEADY STATE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BLOTTING, WESTERN; CEREBRAL CORTEX; COCULTURE TECHNIQUES; DEXAMETHASONE; DOWN-REGULATION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HORMONE ANTAGONISTS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERFERON TYPE II; LIPOPOLYSACCHARIDES; MICROGLIA; MIFEPRISTONE; NEURONS; NEUROPROTECTIVE AGENTS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0344442732     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9568.2003.02917.x     Document Type: Article

References (60)

1. Amin, A.R., Attur, M.G., Thakker, G.D., Patel, P.D., Vyas, P.R., Patel, R.N., Patel, I.R. & Abramson, S.B. (1996) A novel mechanism of action of tetracyclines: effects on nitric oxide synthases. Proc. Natl Acad. Sci. USA, 93, 14014-14019.
2. Asanuma, M., Nishibayashi-Asanuma, S., Miyazaki, I., Kohno, M. & Ogawa, N. (2001) Neuroprotective effects of non-steroidal anti-inflammatory drugs by direct scavenging of nitric oxide radicals. J. Neurochem., 76, 1895-1904.
3. Bagasra, O., Michaels, F.H., Zheng, Y.M., Bobroski, L.E., Spitsin, S.V., Fu, Z.F., Tawadros, R. & Koprowski, H. (1995) Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. Proc. Natl Acad. Sci. USA, 92, 12041-12045.
4. Bal-Price, A. & Brown, G.C. (2001) Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity. J. Neurosci., 21, 6480-6491.
5. Banati, R.B., Newcombe, J., Gunn, R.N., Cagnin, A., Turkheimer, F., Heppner, F., Price, G., Wegner, F., Giovannoni, G., Miller, D.H., Perkin, G.D., Smith, T., Hewson, A.K., Bydder, G., Kreutzberg, G.W., Jones, T., Cuzner, M.L. & Myers, R. (2000) The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. Brain, 123, 2321-2337.
6. Barnes, P.J. & Adcock, I. (1993) Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol. Sci., 14, 436-441.
7. Beato, M., Truss, M. & Chavez, S. (1996) Control of transcription by steroid hormones. Ann. NY Acad. Sci., 784, 93-123.
8. Bitsch, A., Schuchardt, J., Bunkowski, S., Kuhlmann, T. & Bruck, W. (2000) Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. Brain, 123, 1174-1183.
9. Brewer, G.J. & Cotman, C.W. (1989) Survival and growth of hippocampal neurons in defined medium at low density: advantages of a sandwich culture technique or low oxygen. Brain Res., 494, 65-74.
10. Brooke, S., Chan, R., Howard, S. & Sapolsky, R. (1997) Endocrine modulation of the neurotoxicity of gp120: implications for AIDS-related dementia complex. Proc. Natl Acad. Sci. USA, 94, 9457-9462.
11. Brown, G.C. & Borutaite, V. (2001) Nitric oxide, mitochondria, and cell death. IUBMB Life, 52, 189-195.
12. Chan, R.S., Huey, E.D., Maecker, H.L., Cortopassi, K.M., Howard, S.A., Iyer, A.M., McIntosh, L.J., Ajilore, O.A., Brooke, S.M. & Sapolsky, R.M. (1996) Endocrine modulators of necrotic neuron death. Brain Pathol., 6, 481-491.
13. Chao, C.C., Hu, S., Close, K., Choi, C.S., Molitor, T.W., Novick, W.J. & Peterson, P.K. (1992) Cytokine release from microglia: differential inhibition by pentoxifylline and dexamethasone. J. Infect. Dis., 166, 847-853.
14. Corradin, S.B., Mauel, J., Donini, S.D., Quattrocchi, E. & Ricciardi-Castagnoli, P. (1993) Inducible nitric oxide synthase activity of cloned murine microglial cells. Glia, 7, 255-262.
15. Cross, A.H., Manning, P.T., Keeling, R.M., Schmidt. R.E. & Misko, T.P. (1998) Peroxynitrite formation within the central nervous system in active multiple sclerosis. J. Neuroimmunol., 88, 45-56.
16. D'Acquisto, F., Cicatiello, L., Iuvone, T., Ialenti, A., Ianaro, A., Esumi, H., Weisz, A. & Carnuccio, R. (1997) Inhibition of inducible nitric oxide synthase gene expression by glucocorticoid-induced protein (s) in lipopolysaccharide-stimulated J774 cells. Eur. J. Pharmacol., 339, 87-95.
17. De Groot, C.J., Ruuls, S.R., Theeuwes, J.W., Dijkstra, C.D. & Van der Valk, P. (1997) Immunocytochemical characterization of the expression of inducible and constitutive isoforms of nitric oxide synthase in demyelinating multiple sclerosis lesions. J. Neuropathol. Exp. Neurol., 56, 10-20.
18. Drew, P.D. & Chavis, J.A. (2000) Inhibition of microglial cell activation by cortisol. Brain Res. Bull., 52, 391-396.
19. Flavin, M.P., Ho, L.T. & Coughlin, K. (1997) Neurotoxicity of soluble macrophage products in vitro - influence of dexamethasone. Exp. Neurol., 145, 462-470.
20. Forrester, K., Ambs, S., Lupold, S.E., Kapust, R.B., Spillare, E.A., Weinberg, W.C., Felley-Bosco, E., Wang, X.W., Geller, D.A., Tzeng, E., Billiar, T.R. & Harris, C.C. (1996) Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53. Proc. Natl Acad. Sci. USA, 93, 2442-2447.
21. Ganter, S., Northoff, H., Mannel, D. & Gebicke-Harter, P.J. (1992) Growth control of cultured microglia. J. Neurosci. Res., 33, 218-230.
22. Gao, J.J., Filla, M.B., Lorsbach, R.B., Pace, J.L., Crespo, A., Russell, S.W. & Murphy, W.J. (2000) Prolonged exposure of mouse macrophages to IFN-beta suppresses transcription of the inducible nitric oxide synthase gene: altered availability of transcription factor Stat1alpha. Eur. J. Immunol., 30, 1551-1561.
23. Geller, D.A., Nussler, A.K., Di Silvio, M., Lowenstein, C.J., Shapiro, R.A., Wang, S.C., Simmons, R.L. & Billiar, T.R. (1993) Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc. Natl Acad. Sci. USA, 90, 522-526.
24. Giovannoni, G., Heales, S.J., Silver, N.C., O'Riordan, J., Miller, R.F., Land, J.M., Clark, J.B. & Thompson, E.J. (1997) Raised serum nitrate and nitrite levels in patients with multiple sclerosis. J. Neurol. Sci., 145, 77-81.
25. Golde, S., Chandran, S., Brown, G.C. & Compston, A. (2002) Different pathways for iNOS-mediated toxicity in vitro dependent on neuronal maturation and NMDA-receptor expression. J. Neurochem., 82, 269-282.
26. Hall, G.L., Wing, M.G., Compston, D.A. & Scolding, N.J. (1997) beta-Interferon regulates the immunomodulatory activity of neonatal rodent microglia. J. Neuroimmunol., 72, 11-19.
27. Howard, S.A., Nakayama, A.Y., Brooke, S.M. & Sapolsky, R.M. (1999) Glucocorticoid modulation of gp120-induced effects on calcium-dependent degenerative events in primary hippocampal and cortical cultures. Exp. Neurol., 158, 164-170.
28. Johnson, A.W., Land, J.M., Thompson, E.J., Bolanos, J.P., Clark, J.B. & Heales, S.J. (1995) Evidence for increased nitric oxide production in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry, 58, 107.
29. Jonat, C., Rahmsdorf, H.J., Park, K.K., Cato, A.C., Gebel, S., Ponta, H. & Herrlich, P. (1990) Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell, 62, 1189-1204.
30. Jun, C.D., Hoon-Ryu, Um, J.Y., Kim, T.Y., Kim, J.M., Kang, S.S., Kim, H.M. & Chung, H.T. (1994) Involvement of protein kinase C in the inhibition of nitric oxide production from murine microglial cells by glucocorticoid. Biochem. Biophys. Res. Commun., 199, 633-638.
31. Kerr, S.D., Campbell, L.W., Applegate, M.D., Brodish, A. & Landfield, P.W. (1991) Chronic stress-induced acceleration of electrophysiologic and morphometric biomarkers of hippocampal aging. J. Neurosci., 11, 1316-1324.
32. Knowles, R.G., Salter, M., Brooks, S.L. & Moncada, S. (1990) Anti-inflammatory glucocorticoids inhibit the induction by endotoxin of nitric oxide synthase in the lung, liver and aorta of the rat. Biochem. Biophys. Res. Commun., 172, 1042-1048.
33. Kolodziejski, P.J., Musial, A., Koo, J.S. & Eissa, N.T. (2002) Ubiquitination of inducible nitric oxide synthase is required for its degradation. Proc. Natl Acad. Sci. USA, 99, 12315-12320.
34. Korhonen, R., Lahti, A., Hamalainen, M., Kankaanranta, H. & Moilanen, E. (2002) Dexamethasone inhibits inducible nitric-oxide synthase expression and nitric oxide production by destabilizing mRNA in lipopolysaccharide-treated macrophages. Mol. Pharmacol., 62, 698-704.
35. Lasa, M., Brook, M., Saklatvala, J. & Clark, A.R. (2001) Dexamethasone destabilizes cyclooxygenase 2 mRNA by inhibiting mitogen-activated protein kinase p38. Mol. Cell Biol., 21, 771-780.
36. Lopez-Collazo, E., Hortelano, S., Rojas, A. & Bosca, L. (1998) Triggering of peritoneal macrophages with IFN-alpha/beta attenuates the expression of inducible nitric oxide synthase through a decrease in NF-kappaB activation. J. Immunol., 160, 2889-2895.
37. MacMicking, J., Xie, Q.W. & Nathan, C. (1997) Nitric oxide and macrophage function. Annu. Rev. Immunol., 15, 323-350.
38. Matsumura, M., Kakishita, H., Suzuki, M., Banba, N. & Hattori, Y. (2001) Dexamethasone suppresses iNOS gene expression by inhibiting NF-kappaB in vascular smooth muscle cells. Life Sci., 69, 1067-1077.
39. Minghetti, L., Nicolini, A., Polazzi, E., Greco, A., Perretti, M., Parente, L. & Levi, G. (1999) Down-regulation of microglial cyclo-oxygenase-2 and inducible nitric oxide synthase expression by lipocortin 1. Br. J. Pharmacol., 126, 1307-1314.
40. Mukaida, N., Morita, M., Ishikawa, Y., Rice, N., Okamoto, S., Kasahara, T. & Matsushima, K. (1994) Novel mechanism of glucocorticoid-mediated gene repression. Nuclear factor-kappa B is target for glucocorticoid-mediated interleukin 8 gene repression. J. Biol. Chem., 269, 13289-13295.
41. Musial, A. & Eissa, N.T. (2001) Inducible nitric-oxide synthase is regulated by the proteasome degradation pathway. J. Biol. Chem., 276, 24268-24273.
42. Piani, D. & Fontana, A. (1994) Involvement of the cystine transport system xc-in the macrophage-induced glutamate-dependent cytotoxicity to neurons. J. Immunol., 152, 3578-3585.
43. Popovic, N., Schubart, A., Goetz, B.D., Zhang, S.C., Linington, C. & Duncan, I.D. (2002) Inhibition of autoimmune encephalomyelitis by a tetracycline. Ann. Neurol., 51, 215-223.
44. Radomski, M.W., Palmer, R.M. & Moncada, S. (1990) Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc. Natl Acad. Sci. USA, 87, 10043-10047.
45. Sapolsky, R.M., Krey, L.C. & McEwen, B.S. (1986) The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocr. Rev., 7, 284-301.
46. Sarchielli, Pm, Orlacchio, A., Vicinanza, F., Pelliccioli, G.P., Tognoloni, M., Saccardi, C. & Gallai, V. (1997) Cytokine secretion and nitric oxide production by mononuclear cells of patients with multiple sclerosis. J. Neuroimmunol., 80, 76-86.
47. Schubert, U., Anton, L.C., Gibbs, J., Norbury, C.C., Yewdell, J.W. & Bennink. J.R. (2000) Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature, 404, 770-774.
48. Simmons, W.W., Ungureanu-Longrois, D., Smith, G.K., Smith, T.W. & Kelly, R.A. (1996) Glucocorticoids regulate inducible nitric oxide synthase by inhibiting tetrahydrobiopterin synthesis and 1-arginine transport. J. Biol. Chem., 271, 23928-23937.
49. Smith, K.J., Kapoor, R., Hall, S.M. & Davies, M. (2001) Electrically active axons degenerate when exposed to nitric oxide. Ann. Neurol., 49, 470-476.
50. Stewart, V.C., Giovannoni, G., Land, J.M., McDonald, W.I., Clark, J.B. & Heales, S.J. (1997) Pretreatment of astrocytes with interferon-alpha/beta impairs interferon-gamma induction of nitric oxide synthase. J. Neurochem., 68, 2547-2551.
51. Tanaka, J., Fujita, H., Matsuda, S., Toku, K., Sakanaka, M. & Maeda, N. (1997) Glucocorticoid-and mineralocorticoid receptors in microglial cells: the two receptors mediate differential effects of corticosteroids. Glia, 20, 23-37.
52. Tikka, T., Fiebich, B.L., Goldsteins, G., Keinanen, R. & Koistinaho, J. (2001) Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J. Neurosci., 21, 2580-2588.
53. Trapp, B.D., Peterson, J., Ransohoff, R.M., Rudick, R., Mork, S. & Bo, L. (1998) Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med., 338, 278-285.
54. Walker, G., Pfeilschifter, J. & Kunz, D. (1997) Mechanisms of suppression of inducible nitric-oxide synthase (iNOS) expression in Interferon (IFN) -γ-stimulated RAW 264.7 cells by dexamethasone. J. Biol. Chem., 272, 16679-16687.
55. Walker, G., Pfeilschifter, J., Otten, U. & Kunz, D. (2001) Proteolytic cleavage of inducible nitric oxide synthase (iNOS) by calpain I. Biochim. Biophys. Acta, 1568, 216-224.
56. Yamashita, T., Ando, Y., Obayashi, K., Uchino, M. & Ando, M. (1997) Changes in nitrite and nitrate (NO2-/NO3-) levels in cerebrospinal fluid of patients with multiple sclerosis. J. Neurol. Sci., 153, 32-34.
57. Yang, Y.H., Hutchinson, P., Santos, L.L. & Morand, E.F. (1998) Glucocorticoid inhibition of adjuvant arthritis synovial macrophage nitric oxide production: role of lipocortin 1. Clin. Exp. Immunol., 111, 117-122.
58. Yedidia, Y., Horonchik, L., Tzaban, S., Yanai, A. & Taraboulos, A. (2001) Proteasomes and ubiquitin are involved in the turnover of the wild-type prion protein. EMBO J., 20, 5383-5391.
59. Zhang, J., Dawson, V.L., Dawson, T.M. & Snyder, S.H. (1994) Nitric oxide activation of poly (ADP-ribose) synthetase in neurotoxicity. Science, 263, 687-689.
60. Zivadinov, R., Rudick, R.A., De Masi, R., Nasuelli, D., Ukmar, M., Pozzi-Mucelli, R.S., Grop, A., Cazzato, G. & Zorzon, M. (2001) Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS. Neurology, 7, 1239-1247.